FH and familial hyperaldosteronism: Second, we will not require genetic testing for FH for probands who are enrolled in the trial since genetic screening is not yet standard practice in the USA, not all individuals with FH have an identifiable mutation, and genetic screening may not be acceptable or of interest to some individuals even when it is provided free of charge [44].